JCGAがん関連遺伝子 (460遺伝子)
遺伝子 シンボル名 |
遺伝子名 | 染色体上の位置 (GRCh37/hg19) |
遺伝子ID | 転写産物ID (RefSeq) | 遺伝子分類 | 機能分類 | シグナル 伝達経路 |
---|---|---|---|---|---|---|---|
ABCB1 | ATP binding cassette subfamily B member 1 | 7q21.12 | 5243 | NM_000927 | --- | 代謝 | Drug metabolism |
ABCG2 | ATP binding cassette subfamily G member 2 (Junior blood group) | 4q22.1 | 9429 | NM_004827 | --- | 代謝 | Drug metabolism |
ABL1 | ABL proto-oncogene 1, non-receptor tyrosine kinase | 9q34.12 | 25 | NM_005157 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | 1q25.2 | 27 | NM_007314 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
ACTN4 | actinin alpha 4 | 19q13.2 | 81 | NM_004924 | --- | --- | --- |
ACVR1B | activin A receptor type 1B | 12q13.13 | 91 | NM_004302 | がん抑制遺伝子 | 腫瘍形成・増殖 | TGF-B |
ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 4q23 | 125 | NM_000668 | --- | 代謝 | Metabolic pathway |
AIP | aryl hydrocarbon receptor interacting protein | 11q13.2 | 9049 | NM_003977 | --- | --- | --- |
AKT1 | AKT serine/threonine kinase 1 | 14q32.33 | 207 | NM_005163 | がん遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
AKT2 | AKT serine/threonine kinase 2 | 19q13.2 | 208 | NM_001626 | がん遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
AKT3 | AKT serine/threonine kinase 3 | 1q43-q44 | 10000 | NM_005465 | がん遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
ALDH2 | aldehyde dehydrogenase 2 family member | 12q24.12 | 217 | NM_000690 | --- | 代謝 | Drug metabolism |
ALK | ALK receptor tyrosine kinase | 2p23.2-p23.1 | 238 | NM_004304 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
ALOX12B | arachidonate 12-lipoxygenase, 12R type | 17p13.1 | 242 | NM_001139 | --- | 免疫 | Immune |
AMER1 | APC membrane recruitment protein 1 | Xq11.2 | 139285 | NM_152424 | がん抑制遺伝子 | 分化 | WNT |
APC | APC regulator of WNT signaling pathway | 5q22.2 | 324 | NM_001127510 | がん抑制遺伝子 | 分化 | WNT |
AR | androgen receptor | Xq12 | 367 | NM_000044 | がん遺伝子 | 腫瘍形成・増殖 | Nuclear receptor |
ARAF | A-Raf proto-oncogene, serine/threonine kinase | Xp11.3 | 369 | NM_001654 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
ARFRP1 | ADP ribosylation factor related protein 1 | 20q13.33 | 10139 | NM_001267547 | --- | --- | --- |
ARID1A | AT-rich interaction domain 1A | 1p36.11 | 8289 | NM_006015 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
ARID1B | AT-rich interaction domain 1B | 6q25.3 | 57492 | NM_017519 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
ARID2 | AT-rich interaction domain 2 | 12q12 | 196528 | NM_152641 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
ASXL1 | ASXL transcriptional regulator 1 | 20q11.21 | 171023 | NM_015338 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
ATF1 | activating transcription factor 1 | 12q13.12 | 466 | NM_005171 | がん遺伝子 | 転写制御 | Transcriptional regulation |
ATM | ATM serine/threonine kinase | 11q22.3 | 472 | NM_000051 | がん抑制遺伝子 | ゲノム安定性の維持 | TP53 |
ATR | ATR serine/threonine kinase | 3q23 | 545 | NM_001184 | がん抑制遺伝子 | ゲノム安定性の維持 | TP53 |
ATRX | ATRX chromatin remodeler | Xq21.1 | 546 | NM_000489 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
AURKA | aurora kinase A | 20q13.2 | 6790 | NM_198433 | がん遺伝子 | 細胞周期 | Cell division |
AURKB | aurora kinase B | 17p13.1 | 9212 | NM_004217 | がん遺伝子 | 細胞周期 | Cell division |
AXIN1 | axin 1 | 16p13.3 | 8312 | NM_003502 | がん抑制遺伝子 | 分化 | WNT |
AXL | AXL receptor tyrosine kinase | 19q13.2 | 558 | NM_021913 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
B2M | beta-2-microglobulin | 15q21.1 | 567 | NM_004048 | がん抑制遺伝子 | 免疫 | Immune |
BAP1 | BRCA1 associated protein 1 | 3p21.1 | 8314 | NM_004656 | がん抑制遺伝子 | タンパク質の恒常性の維持 | Protein homeostasis |
BARD1 | BRCA1 associated RING domain 1 | 2q35 | 580 | NM_000465 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
BAX | BCL2 associated X, apoptosis regulator | 19q13.33 | 581 | NM_138761 | がん抑制遺伝子 | 細胞死 | Apoptosis |
BCL10 | BCL10 immune signaling adaptor | 1p22.3 | 8915 | NM_003921 | がん抑制遺伝子 | 腫瘍形成・増殖 | NFKB |
BCL2 | BCL2 apoptosis regulator | 18q21.33 | 596 | NM_000633 | がん遺伝子 | 細胞死 | Apoptosis |
BCL2L1 | BCL2 like 1 | 20q11.21 | 598 | NM_138578 | がん遺伝子 | 細胞死 | Apoptosis |
BCL2L11 | BCL2 like 11 | 2q13 | 10018 | NM_138621 | がん抑制遺伝子 | 細胞死 | Apoptosis |
BCL2L2 | BCL2 like 2 | 14q11.2 | 599 | NM_004050 | --- | 細胞死 | Apoptosis |
BCL6 | BCL6 transcription repressor | 3q27.3 | 604 | NM_001130845 | がん遺伝子 | 免疫 | Immune |
BCOR | BCL6 corepressor | Xp11.4 | 54880 | NM_001123385 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
BCORL1 | BCL6 corepressor like 1 | Xq26.1 | 63035 | NM_021946 | がん遺伝子 / がん抑制遺伝子 |
エピジェネティック制御 | Epigenetic modification |
BCR | BCR activator of RhoGEF and GTPase | 22q11.23 | 613 | NM_004327 | がん遺伝子 | --- | --- |
BLM | BLM RecQ like helicase | 15q26.1 | 641 | NM_001287246 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
BMPR1A | bone morphogenetic protein receptor type 1A | 10q23.2 | 657 | NM_004329 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | TGF-B |
BRAF | B-Raf proto-oncogene, serine/threonine kinase | 7q34 | 673 | NM_004333 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
BRCA1 | BRCA1 DNA repair associated | 17q21.31 | 672 | NM_007294 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
BRCA2 | BRCA2 DNA repair associated | 13q13.1 | 675 | NM_000059 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
BRD4 | bromodomain containing 4 | 19p13.12 | 23476 | NM_058243 | がん遺伝子 | 転写制御 | Transcriptional regulation |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | 17q23.2 | 83990 | NM_032043 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
BTG1 | BTG anti-proliferation factor 1 | 12q21.33 | 694 | NM_001731 | がん抑制遺伝子 | 転写制御 | RNA metabolism |
BTG2 | BTG anti-proliferation factor 2 | 1q32.1 | 7832 | NM_006763 | --- | 細胞周期 | Cell cycle |
BTK | Bruton tyrosine kinase | Xq22.1 | 695 | NM_000061 | がん遺伝子 / がん抑制遺伝子 |
免疫 | Immune |
CALR | calreticulin | 19p13.13 | 811 | NM_004343 | がん遺伝子 | 腫瘍形成・増殖 | JAK/STAT |
CARD11 | caspase recruitment domain family member 11 | 7p22.2 | 84433 | NM_001324281 | がん遺伝子 | 腫瘍形成・増殖 | NFKB |
CASP8 | caspase 8 | 2q33.1 | 841 | NM_033355 | がん抑制遺伝子 | 細胞死 | Apoptosis |
CBFB | core-binding factor subunit beta | 16q22.1 | 865 | NM_001755 | がん抑制遺伝子 | 転写制御 | Transcriptional regulation |
CBL | Cbl proto-oncogene | 11q23.3 | 867 | NM_005188 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | RTK |
CCDC6 | coiled-coil domain containing 6 | 10q21.2 | 8030 | NM_005436 | がん抑制遺伝子 | --- | --- |
CCND1 | cyclin D1 | 11q13.3 | 595 | NM_053056 | がん遺伝子 | 細胞周期 | Cell cycle |
CCND2 | cyclin D2 | 12p13.32 | 894 | NM_001759 | がん遺伝子 | 細胞周期 | Cell cycle |
CCND3 | cyclin D3 | 6p21.1 | 896 | NM_001760 | がん遺伝子 | 細胞周期 | Cell cycle |
CCNE1 | cyclin E1 | 19q12 | 898 | NM_001238 | がん遺伝子 | 細胞周期 | Cell cycle |
CD22 | CD22 molecule | 19q13.12 | 933 | NM_001771 | --- | 免疫 | Immune |
CD274 | CD274 molecule | 9p24.1 | 29126 | NM_014143 | がん遺伝子 / がん抑制遺伝子 |
免疫 | Immune |
CD70 | CD70 molecule | 19p13.3 | 970 | NM_001252 | --- | 免疫 | Immune |
CD74 | CD74 molecule | 5q33.1 | 972 | NM_001025159 | がん遺伝子 | 免疫 | Immune |
CD79A | CD79a molecule | 19q13.2 | 973 | NM_001783 | がん遺伝子 | 免疫 | Immune |
CD79B | CD79b molecule | 17q23.3 | 974 | NM_000626 | がん遺伝子 | 免疫 | Immune |
CDA | cytidine deaminase | 1p36.12 | 978 | NM_001785 | --- | 代謝 | Drug metabolism |
CDC73 | cell division cycle 73 | 1q31.2 | 79577 | NM_024529 | がん抑制遺伝子 | 転写制御 | Transcriptional regulation |
CDH1 | cadherin 1 | 16q22.1 | 999 | NM_004360 | がん抑制遺伝子 | 分化 | WNT |
CDH23 | cadherin related 23 | 10q22.1 | 64072 | NM_022124 | --- | --- | --- |
CDK12 | cyclin dependent kinase 12 | 17q12 | 51755 | NM_016507 | がん抑制遺伝子 | 転写制御 | Transcriptional regulation |
CDK4 | cyclin dependent kinase 4 | 12q14.1 | 1019 | NM_000075 | がん遺伝子 | 細胞周期 | Cell cycle |
CDK6 | cyclin dependent kinase 6 | 7q21.2 | 1021 | NM_001145306 | がん遺伝子 | 細胞周期 | Cell cycle |
CDK8 | cyclin dependent kinase 8 | 13q12.13 | 1024 | NM_001260 | がん遺伝子 | 転写制御 | Transcriptional regulation |
CDKN1A | cyclin dependent kinase inhibitor 1A | 6p21.2 | 1026 | NM_001220778 | がん遺伝子 / がん抑制遺伝子 |
細胞周期 | Cell cycle |
CDKN1B | cyclin dependent kinase inhibitor 1B | 12p13.1 | 1027 | NM_004064 | がん抑制遺伝子 | 細胞周期 | Cell cycle |
CDKN2A | cyclin dependent kinase inhibitor 2A | 9p21.3 | 1029 | NM_000077 | がん抑制遺伝子 | 細胞周期 | Cell cycle |
CDKN2B | cyclin dependent kinase inhibitor 2B | 9p21.3 | 1030 | NM_004936 | がん抑制遺伝子 | 細胞周期 | Cell cycle |
CDKN2C | cyclin dependent kinase inhibitor 2C | 1p32.3 | 1031 | NM_001262 | がん抑制遺伝子 | 細胞周期 | Cell cycle |
CEBPA | CCAAT enhancer binding protein alpha | 19q13.11 | 1050 | NM_004364 | がん抑制遺伝子 | 転写制御 | Transcriptional regulation |
CHCHD7 | coiled-coil-helix-coiled-coil-helix domain containing 7 | 8q12.1 | 79145 | NM_001011671 | --- | --- | --- |
CHEK1 | checkpoint kinase 1 | 11q24.2 | 1111 | NM_001114122 | がん抑制遺伝子 | ゲノム安定性の維持 | TP53 |
CHEK2 | checkpoint kinase 2 | 22q12.1 | 11200 | NM_007194 | がん遺伝子 / がん抑制遺伝子 |
ゲノム安定性の維持 | TP53 |
CIC | capicua transcriptional repressor | 19q13.2 | 23152 | NM_015125 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | MAPK |
COL1A1 | collagen type I alpha 1 chain | 17q21.33 | 1277 | NM_000088 | --- | --- | --- |
COMT | catechol-O-methyltransferase | 22q11.21 | 1312 | NM_000754 | --- | 代謝 | Drug metabolism |
CREBBP | CREB binding protein | 16p13.3 | 1387 | NM_004380 | がん遺伝子 / がん抑制遺伝子 |
エピジェネティック制御 | Epigenetic modification |
CRKL | CRK like proto-oncogene, adaptor protein | 22q11.21 | 1399 | NM_005207 | がん遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
CRLF2 | cytokine receptor like factor 2 | Xp22.33 / Yp11.2 | 64109 | NM_022148 | がん遺伝子 | 腫瘍形成・増殖 | JAK/STAT |
CRTC3 | CREB regulated transcription coactivator 3 | 15q26.1 | 64784 | NM_022769 | --- | 転写制御 | Transcriptional regulation |
CSF1R | colony stimulating factor 1 receptor | 5q32 | 1436 | NM_001288705 | がん遺伝子 | 免疫 | Immune |
CSF3R | colony stimulating factor 3 receptor | 1p34.3 | 1441 | NM_000760 | がん遺伝子 | 腫瘍形成・増殖 | JAK/STAT |
CTCF | CCCTC-binding factor | 16q22.1 | 10664 | NM_006565 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
CTLA4 | cytotoxic T-lymphocyte associated protein 4 | 2q33.2 | 1493 | NM_005214 | がん遺伝子 | 免疫 | Immune |
CTNNA1 | catenin alpha 1 | 5q31.2 | 1495 | NM_001323982 | --- | 分化 | WNT |
CTNNB1 | catenin beta 1 | 3p22.1 | 1499 | NM_001904 | がん遺伝子 | 分化 | WNT |
CUL3 | cullin 3 | 2q36.2 | 8452 | NM_003590 | がん抑制遺伝子 | 酸化ストレス応答 | KEAP1/NRF2 |
CUL4A | cullin 4A | 13q34 | 8451 | NM_001008895 | --- | タンパク質の恒常性の維持 | Protein homeostasis |
CXCR4 | C-X-C motif chemokine receptor 4 | 2q22.1 | 7852 | NM_003467 | がん遺伝子 | 腫瘍形成・増殖 | GPCR |
CYLD | CYLD lysine 63 deubiquitinase | 16q12.1 | 1540 | NM_015247 | がん抑制遺伝子 | タンパク質の恒常性の維持 | Protein homeostasis |
CYP17A1 | cytochrome P450 family 17 subfamily A member 1 | 10q24.32 | 1586 | NM_000102 | --- | 代謝 | Metabolic pathway |
CYP1A2 | cytochrome P450 family 1 subfamily A member 2 | 15q24.1 | 1544 | NM_000761 | --- | 代謝 | Drug metabolism |
CYP2A6 | cytochrome P450 family 2 subfamily A member 6 | 19q13.2 | 1548 | NM_000762 | --- | 代謝 | Drug metabolism |
CYP2B6 | cytochrome P450 family 2 subfamily B member 6 | 19q13.2 | 1555 | NM_000767 | --- | 代謝 | Drug metabolism |
CYP2C19 | cytochrome P450 family 2 subfamily C member 19 | 10q23.33 | 1557 | NM_000769 | --- | 代謝 | Drug metabolism |
CYP2C9 | cytochrome P450 family 2 subfamily C member 9 | 10q23.33 | 1559 | NM_000771 | --- | 代謝 | Drug metabolism |
CYP2D6 | cytochrome P450 family 2 subfamily D member 6 | 22q13.2 | 1565 | NM_000106 | --- | 代謝 | Drug metabolism |
CYP2E1 | cytochrome P450 family 2 subfamily E member 1 | 10q26.3 | 1571 | NM_000773 | --- | 代謝 | Drug metabolism |
CYP3A4 | cytochrome P450 family 3 subfamily A member 4 | 7q22.1 | 1576 | NM_017460 | --- | 代謝 | Drug metabolism |
CYP3A43 | cytochrome P450 family 3 subfamily A member 43 | 7q22.1 | 64816 | NM_057095 | --- | 代謝 | Metabolic pathway |
CYP3A5 | cytochrome P450 family 3 subfamily A member 5 | 7q22.1 | 1577 | NM_000777 | --- | 代謝 | Drug metabolism |
DAXX | death domain associated protein | 6p21.32 | 1616 | NM_001141969 | がん遺伝子 / がん抑制遺伝子 |
細胞死 | Apoptosis |
DDIT3 | DNA damage inducible transcript 3 | 12q13.3 | 1649 | NM_004083 | がん遺伝子 | 転写制御 | Transcriptional regulation |
DDR1 | discoidin domain receptor tyrosine kinase 1 | 6p21.33 | 780 | NM_013993 | --- | 腫瘍形成・増殖 | RTK |
DDR2 | discoidin domain receptor tyrosine kinase 2 | 1q23.3 | 4921 | NM_001014796 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
DICER1 | dicer 1, ribonuclease III | 14q32.13 | 23405 | NM_030621 | がん抑制遺伝子 | 転写制御 | RNA metabolism |
DIS3 | DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease | 13q21.33 | 22894 | NM_014953 | --- | 転写制御 | RNA metabolism |
DNAAF1 | dynein axonemal assembly factor 1 | 16q24.1 | 123872 | NM_178452 | --- | --- | --- |
DNMT1 | DNA methyltransferase 1 | 19p13.2 | 1786 | NM_001379 | がん遺伝子 | エピジェネティック制御 | Epigenetic modification |
DNMT3A | DNA methyltransferase 3 alpha | 2p23.3 | 1788 | NM_175629 | がん遺伝子 / がん抑制遺伝子 |
エピジェネティック制御 | Epigenetic modification |
DOT1L | DOT1 like histone lysine methyltransferase | 19p13.3 | 84444 | NM_032482 | --- | エピジェネティック制御 | Epigenetic modification |
DPYD | dihydropyrimidine dehydrogenase | 1p21.3 | 1806 | NM_000110 | --- | 代謝 | Drug metabolism |
EED | embryonic ectoderm development | 11q14.2 | 8726 | NM_003797 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
EGFR | epidermal growth factor receptor | 7p11.2 | 1956 | NM_005228 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
EIF3E | eukaryotic translation initiation factor 3 subunit E | 8q23.1 | 3646 | NM_001568 | がん抑制遺伝子 | 転写制御 | RNA metabolism |
EML4 | EMAP like 4 | 2p21 | 27436 | NM_019063 | --- | --- | --- |
EMSY | EMSY transcriptional repressor, BRCA2 interacting | 11q13.5 | 56946 | NM_020193 | --- | --- | --- |
ENG | endoglin | 9q34.11 | 2022 | NM_001114753 | --- | 腫瘍形成・増殖 | TGF-B |
ENO1 | enolase 1 | 1p36.23 | 2023 | NM_001428 | --- | タンパク質の恒常性の維持 | Protein homeostasis |
EP300 | E1A binding protein p300 | 22q13.2 | 2033 | NM_001429 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
EPAS1 | endothelial PAS domain protein 1 | 2p21 | 2034 | NM_001430 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | PI3K/Akt/mTOR |
EPCAM | epithelial cell adhesion molecule | 2p21 | 4072 | NM_002354 | がん抑制遺伝子 | --- | --- |
EPHA3 | EPH receptor A3 | 3p11.1 | 2042 | NM_005233 | がん抑制遺伝子 | 腫瘍形成・増殖 | RTK |
EPHB1 | EPH receptor B1 | 3q22.2 | 2047 | NM_004441 | --- | 腫瘍形成・増殖 | RTK |
EPHB4 | EPH receptor B4 | 7q22.1 | 2050 | NM_004444 | --- | 腫瘍形成・増殖 | RTK |
ERBB2 | erb-b2 receptor tyrosine kinase 2 | 17q12 | 2064 | NM_004448 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
ERBB3 | erb-b2 receptor tyrosine kinase 3 | 12q13.2 | 2065 | NM_001982 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
ERBB4 | erb-b2 receptor tyrosine kinase 4 | 2q34 | 2066 | NM_005235 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | RTK |
ERCC2 | ERCC excision repair 2, TFIIH core complex helicase subunit | 19q13.32 | 2068 | NM_000400 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
ERCC4 | ERCC excision repair 4, endonuclease catalytic subunit | 16p13.12 | 2072 | NM_005236 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
ERG | ETS transcription factor ERG | 21q22.2 | 2078 | NM_001243428 | がん遺伝子 | 転写制御 | Transcriptional regulation |
ERRFI1 | ERBB receptor feedback inhibitor 1 | 1p36.23 | 54206 | NM_018948 | がん抑制遺伝子 | 腫瘍形成・増殖 | RTK |
ESR1 | estrogen receptor 1 | 6q25.1-q25.2 | 2099 | NM_001122742 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | Nuclear receptor |
ETV4 | ETS variant transcription factor 4 | 17q21.31 | 2118 | NM_001079675 | がん遺伝子 | 転写制御 | Transcriptional regulation |
ETV5 | ETS variant transcription factor 5 | 3q27.2 | 2119 | NM_004454 | がん遺伝子 | 転写制御 | Transcriptional regulation |
ETV6 | ETS variant transcription factor 6 | 12p13.2 | 2120 | NM_001987 | がん抑制遺伝子 | 転写制御 | Transcriptional regulation |
EWSR1 | EWS RNA binding protein 1 | 22q12.2 | 2130 | NM_005243 | がん遺伝子 | 転写制御 | RNA metabolism |
EXT1 | exostosin glycosyltransferase 1 | 8q24.11 | 2131 | NM_000127 | がん抑制遺伝子 | 代謝 | Metabolic pathway |
EXT2 | exostosin glycosyltransferase 2 | 11p11.2 | 2132 | NM_207122 | がん抑制遺伝子 | 代謝 | Metabolic pathway |
EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit | 7q36.1 | 2146 | NM_001203247 | がん遺伝子 / がん抑制遺伝子 |
エピジェネティック制御 | Epigenetic modification |
EZR | ezrin | 6q25.3 | 7430 | NM_003379 | --- | --- | --- |
TENT5C | terminal nucleotidyltransferase 5C | 1p12 | 54855 | NM_017709 | がん抑制遺伝子 | 転写制御 | RNA metabolism |
FANCA | FA complementation group A | 16q24.3 | 2175 | NM_000135 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
FANCC | FA complementation group C | 9q22.32 | 2176 | NM_000136 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
FANCG | FA complementation group G | 9p13.3 | 2189 | NM_004629 | がん抑制遺伝子 | ゲノム安定性の維持 | DNA damage control |
FANCL | FA complementation group L | 2p16.1 | 55120 | NM_018062 | --- | ゲノム安定性の維持 | Core DNA Damage Response |
FAS | Fas cell surface death receptor | 10q23.31 | 355 | NM_000043 | がん抑制遺伝子 | 細胞死 | Apoptosis |
FAT1 | FAT atypical cadherin 1 | 4q35.2 | 2195 | NM_005245 | がん抑制遺伝子 | 分化 | WNT |
FBXW7 | F-box and WD repeat domain containing 7 | 4q31.3 | 55294 | NM_033632 | がん抑制遺伝子 | タンパク質の恒常性の維持 | Protein homeostasis |
FGF10 | fibroblast growth factor 10 | 5p12 | 2255 | NM_004465 | --- | 腫瘍形成・増殖 | RTK |
FGF12 | fibroblast growth factor 12 | 3q28-q29 | 2257 | NM_021032 | --- | 腫瘍形成・増殖 | RTK |
FGF14 | fibroblast growth factor 14 | 13q33.1 | 2259 | NM_004115 | --- | 腫瘍形成・増殖 | RTK |
FGF19 | fibroblast growth factor 19 | 11q13.3 | 9965 | NM_005117 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
FGF23 | fibroblast growth factor 23 | 12p13.32 | 8074 | NM_020638 | --- | 腫瘍形成・増殖 | RTK |
FGF3 | fibroblast growth factor 3 | 11q13.3 | 2248 | NM_005247 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
FGF4 | fibroblast growth factor 4 | 11q13.3 | 2249 | NM_002007 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
FGF6 | fibroblast growth factor 6 | 12p13.32 | 2251 | NM_020996 | --- | 腫瘍形成・増殖 | RTK |
FGFR1 | fibroblast growth factor receptor 1 | 8p11.23 | 2260 | NM_023110 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
FGFR2 | fibroblast growth factor receptor 2 | 10q26.13 | 2263 | NM_000141 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
FGFR3 | fibroblast growth factor receptor 3 | 4p16.3 | 2261 | NM_000142 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
FGFR4 | fibroblast growth factor receptor 4 | 5q35.2 | 2264 | NM_213647 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
FH | fumarate hydratase | 1q43 | 2271 | NM_000143 | がん抑制遺伝子 | 代謝 | Metabolic pathway |
FLCN | folliculin | 17p11.2 | 201163 | NM_144997 | がん抑制遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
FLT1 | fms related receptor tyrosine kinase 1 | 13q12.3 | 2321 | NM_002019 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
FLT3 | fms related receptor tyrosine kinase 3 | 13q12.2 | 2322 | NM_004119 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
FOXL2 | forkhead box L2 | 3q22.3 | 668 | NM_023067 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
FUBP1 | far upstream element binding protein 1 | 1p31.1 | 8880 | NM_003902 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
FUS | FUS RNA binding protein | 16p11.2 | 2521 | NM_004960 | がん抑制遺伝子 | 転写制御 | Transcriptional regulation |
G6PD | glucose-6-phosphate dehydrogenase | Xq28 | 2539 | NM_001042351 | --- | 代謝 | Metabolic pathway |
GABRA6 | gamma-aminobutyric acid type A receptor subunit alpha6 | 5q34 | 2559 | NM_000811 | --- | --- | --- |
GALNT12 | polypeptide N-acetylgalactosaminyltransferase 12 | 9q22.33 | 79695 | NM_024642 | --- | 代謝 | Metabolic pathway |
GATA3 | GATA binding protein 3 | 10p14 | 2625 | NM_002051 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
GATA4 | GATA binding protein 4 | 8p23.1 | 2626 | NM_002052 | --- | 転写制御 | Transcriptional regulation |
GATA6 | GATA binding protein 6 | 18q11.2 | 2627 | NM_005257 | --- | 転写制御 | Transcriptional regulation |
GID4 | GID complex subunit 4 homolog | 17p11.2 | 79018 | NM_024052 | --- | --- | --- |
GNA11 | G protein subunit alpha 11 | 19p13.3 | 2767 | NM_002067 | がん遺伝子 | 腫瘍形成・増殖 | GPCR |
GNA13 | G protein subunit alpha 13 | 17q24.1 | 10672 | NM_006572 | がん遺伝子 | 腫瘍形成・増殖 | GPCR |
GNAQ | G protein subunit alpha q | 9q21.2 | 2776 | NM_002072 | がん遺伝子 | 腫瘍形成・増殖 | GPCR |
GNAS | GNAS complex locus | 20q13.32 | 2778 | NM_080425 | がん遺伝子 | 腫瘍形成・増殖 | GPCR |
GRM3 | glutamate metabotropic receptor 3 | 7q21.11-q21.12 | 2913 | NM_000840 | がん遺伝子 | 腫瘍形成・増殖 | GPCR |
GSK3B | glycogen synthase kinase 3 beta | 3q13.33 | 2932 | NM_001146156 | がん遺伝子 / がん抑制遺伝子 |
分化 | WNT |
H3-3A | H3.3 histone A | 1q42.12 | 3020 | NM_002107 | がん遺伝子 | エピジェネティック制御 | Epigenetic modification |
HDAC1 | histone deacetylase 1 | 1p35.2-p35.1 | 3065 | NM_004964 | がん遺伝子 | エピジェネティック制御 | Epigenetic modification |
HDAC2 | histone deacetylase 2 | 6q21 | 3066 | NM_001527 | --- | 分化 | NOTCH |
HEY1 | hes related family bHLH transcription factor with YRPW motif 1 | 8q21.13 | 23462 | NM_012258 | がん遺伝子 / がん抑制遺伝子 |
分化 | NOTCH |
HGF | hepatocyte growth factor | 7q21.11 | 3082 | NM_000601 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
HMGA2 | high mobility group AT-hook 2 | 12q14.3 | 8091 | NM_003483 | がん遺伝子 | 転写制御 | Transcriptional regulation |
HNF1A | HNF1 homeobox A | 12q24.31 | 6927 | NM_000545 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
HOXB13 | homeobox B13 | 17q21.32 | 10481 | NM_006361 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
HRAS | HRas proto-oncogene, GTPase | 11p15.5 | 3265 | NM_001130442 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
HSD3B1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | 1p12 | 3283 | NM_000862 | --- | 代謝 | Metabolic pathway |
ID3 | inhibitor of DNA binding 3, HLH protein | 1p36.12 | 3399 | NM_002167 | がん抑制遺伝子 | 転写制御 | Transcriptional regulation |
IDH1 | isocitrate dehydrogenase (NADP(+)) 1 | 2q34 | 3417 | NM_001282387 | がん遺伝子 | エピジェネティック制御 | Epigenetic modification |
IDH2 | isocitrate dehydrogenase (NADP(+)) 2 | 15q26.1 | 3418 | NM_002168 | がん遺伝子 | エピジェネティック制御 | Epigenetic modification |
IGF1R | insulin like growth factor 1 receptor | 15q26.3 | 3480 | NM_000875 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
IGF2 | insulin like growth factor 2 | 11p15.5 | 3481 | NM_000612 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
IKBKE | inhibitor of nuclear factor kappa B kinase subunit epsilon | 1q32.1 | 9641 | NM_014002 | がん遺伝子 | 腫瘍形成・増殖 | NFKB |
IKZF1 | IKAROS family zinc finger 1 | 7p12.2 | 10320 | NM_006060 | がん抑制遺伝子 | 転写制御 | Transcriptional regulation |
IL7R | interleukin 7 receptor | 5p13.2 | 3575 | NM_002185 | がん遺伝子 | 免疫 | Immune |
INPP4B | inositol polyphosphate-4-phosphatase type II B | 4q31.21 | 8821 | NM_003866 | がん抑制遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
IRF2 | interferon regulatory factor 2 | 4q35.1 | 3660 | NM_002199 | --- | 免疫 | Immune |
IRF4 | interferon regulatory factor 4 | 6p25.3 | 3662 | NM_002460 | がん遺伝子 / がん抑制遺伝子 |
免疫 | Immune |
IRS2 | insulin receptor substrate 2 | 13q34 | 8660 | NM_003749 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
JAK1 | Janus kinase 1 | 1p31.3 | 3716 | NM_001321853 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | JAK/STAT |
JAK2 | Janus kinase 2 | 9p24.1 | 3717 | NM_001322194 | がん遺伝子 | 腫瘍形成・増殖 | JAK/STAT |
JAK3 | Janus kinase 3 | 19p13.11 | 3718 | NM_000215 | がん遺伝子 | 腫瘍形成・増殖 | JAK/STAT |
JUN | Jun proto-oncogene, AP-1 transcription factor subunit | 1p32.1 | 3725 | NM_002228 | がん遺伝子 | 転写制御 | Transcriptional regulation |
KDM5A | lysine demethylase 5A | 12p13.33 | 5927 | NM_001042603 | がん遺伝子 | エピジェネティック制御 | Epigenetic modification |
KDM5C | lysine demethylase 5C | Xp11.22 | 8242 | NM_004187 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
KDM6A | lysine demethylase 6A | Xp11.3 | 7403 | NM_021140 | がん遺伝子 / がん抑制遺伝子 |
エピジェネティック制御 | Epigenetic modification |
KDR | kinase insert domain receptor | 4q12 | 3791 | NM_002253 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
KEAP1 | kelch like ECH associated protein 1 | 19p13.2 | 9817 | NM_203500 | がん抑制遺伝子 | 酸化ストレス応答 | KEAP1/NRF2 |
KEL | Kell metallo-endopeptidase (Kell blood group) | 7q34 | 3792 | NM_000420 | --- | --- | --- |
KIAA1549 | KIAA1549 | 7q34 | 57670 | NM_001164665 | --- | --- | --- |
KIF1B | kinesin family member 1B | 1p36.22 | 23095 | NM_015074 | --- | --- | --- |
KIF5B | kinesin family member 5B | 10p11.22 | 3799 | NM_004521 | --- | --- | --- |
KIT | KIT proto-oncogene, receptor tyrosine kinase | 4q12 | 3815 | NM_000222 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
KLF4 | Kruppel like factor 4 | 9q31.2 | 9314 | NM_001314052 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
KLHL6 | kelch like family member 6 | 3q27.1 | 89857 | NM_130446 | --- | --- | --- |
KMT2A | lysine methyltransferase 2A | 11q23.3 | 4297 | NM_005933 | がん遺伝子 / がん抑制遺伝子 |
エピジェネティック制御 | Epigenetic modification |
KMT2C | lysine methyltransferase 2C | 7q36.1 | 58508 | NM_170606 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
KMT2D | lysine methyltransferase 2D | 12q13.12 | 8085 | NM_003482 | がん遺伝子 / がん抑制遺伝子 |
エピジェネティック制御 | Epigenetic modification/td> |
KNSTRN | kinetochore localized astrin (SPAG5) binding protein | 15q15.1 | 90417 | NM_033286 | がん遺伝子 | 細胞周期 | Cell division |
KRAS | KRAS proto-oncogene, GTPase | 12p12.1 | 3845 | NM_033360 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
LMO1 | LIM domain only 1 | 11p15.4 | 4004 | NM_002315 | がん遺伝子 | 転写制御 | Transcriptional regulation |
LRP5 | LDL receptor related protein 5 | 11q13.2 | 4041 | NM_002335 | がん遺伝子 | 分化 | WNT |
LTK | leukocyte receptor tyrosine kinase | 15q15.1 | 4058 | NM_002344 | --- | --- | --- |
LYN | LYN proto-oncogene, Src family tyrosine kinase | 8q12.1 | 4067 | NM_002350 | がん遺伝子 | 免疫 | Immune |
LZTR1 | leucine zipper like transcription regulator 1 | 22q11.21, 22q11.1-q11.2 | 8216 | NM_006767 | がん抑制遺伝子 | 腫瘍形成・増殖 | MAPK |
MAF | MAF bZIP transcription factor | 16q23.2 | 4094 | NM_001031804 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
MAML2 | mastermind like transcriptional coactivator 2 | 11q21 | 84441 | NM_032427 | がん遺伝子 | 分化 | NOTCH |
MAP2K1 | mitogen-activated protein kinase kinase 1 | 15q22.31 | 5604 | NM_002755 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
MAP2K2 | mitogen-activated protein kinase kinase 2 | 19p13.3 | 5605 | NM_030662 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
MAP2K4 | mitogen-activated protein kinase kinase 4 | 17p12 | 6416 | NM_003010 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | MAPK |
MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 5q11.2 | 4214 | NM_005921 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | MAPK |
MAP3K13 | mitogen-activated protein kinase kinase kinase 13 | 3q27.2 | 9175 | NM_004721 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | MAPK |
MAP3K4 | mitogen-activated protein kinase kinase kinase 4 | 6q26 | 4216 | NM_005922 | --- | 腫瘍形成・増殖 | MAPK |
MAPK1 | mitogen-activated protein kinase 1 | 22q11.22 | 5594 | NM_002745 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
MAX | MYC associated factor X | 14q23.3 | 4149 | NM_002382 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | MYC |
MC1R | melanocortin 1 receptor | 16q24.3 | 4157 | NM_002386 | --- | --- | --- |
MCL1 | MCL1 apoptosis regulator, BCL2 family member | 1q21.2 | 4170 | NM_021960 | がん遺伝子 | 細胞死 | Apoptosis |
MDM2 | MDM2 proto-oncogene | 12q15 | 4193 | NM_002392 | がん遺伝子 | ゲノム安定性の維持 | TP53 |
MDM4 | MDM4 regulator of p53 | 1q32.1 | 4194 | NM_002393 | がん遺伝子 | ゲノム安定性の維持 | TP53 |
MED12 | mediator complex subunit 12 | Xq13.1 | 9968 | NM_005120 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
MEF2B | myocyte enhancer factor 2B | 19p13.11 | 100271849 | NM_001145785 | がん遺伝子 | 転写制御 | Transcriptional regulation |
MEN1 | menin 1 | 11q13.1 | 4221 | NM_130803 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
MERTK | MER proto-oncogene, tyrosine kinase | 2q13 | 10461 | NM_006343 | --- | --- | --- |
MET | MET proto-oncogene, receptor tyrosine kinase | 7q31.2 | 4233 | NM_000245 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
MITF | melanocyte inducing transcription factor | 3p13 | 4286 | NM_198159 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
MKNK1 | MAPK interacting serine/threonine kinase 1 | 1p33 | 8569 | NM_003684 | --- | 腫瘍形成・増殖 | MAPK |
MKRN1 | makorin ring finger protein 1 | 7q34 | 23608 | NM_013446 | --- | タンパク質の恒常性の維持 | Protein homeostasis |
MLH1 | mutL homolog 1 | 3p22.2 | 4292 | NM_000249 | がん遺伝子 / がん抑制遺伝子 |
ゲノム安定性の維持 | Core DNA Damage Response |
MPL | MPL proto-oncogene, thrombopoietin receptor | 1p34.2 | 4352 | NM_005373 | がん遺伝子 | 腫瘍形成・増殖 | JAK/STAT |
MRE11 | MRE11 homolog, double strand break repair nuclease | 11q21 | 4361 | NM_005591 | --- | ゲノム安定性の維持 | Core DNA Damage Response |
MSH2 | mutS homolog 2 | 2p21-p16.3 | 4436 | NM_000251 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
MSH3 | mutS homolog 3 | 5q14.1 | 4437 | NM_002439 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
MSH6 | mutS homolog 6 | 2p16.3 | 2956 | NM_000179 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
MST1R | macrophage stimulating 1 receptor | 3p21.31 | 4486 | NM_002447 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
MTAP | methylthioadenosine phosphorylase | 9p21.3 | 4507 | NM_002451 | --- | 代謝 | Metabolic pathway |
MTHFR | methylenetetrahydrofolate reductase | 1p36.22 | 4524 | NM_005957 | --- | 代謝 | Drug metabolism |
MTOR | mechanistic target of rapamycin kinase | 1p36.22 | 2475 | NM_004958 | がん遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
MTRR | 5-methyltetrahydrofolate-homocysteine methyltransferase reductase | 5p15.31 | 4552 | NM_024010 | --- | 代謝 | Metabolic pathway |
MUTYH | mutY DNA glycosylase | 1p34.1 | 4595 | NM_012222 | がん抑制遺伝子 | ゲノム安定性の維持 | DNA damage control |
MXI1 | MAX interactor 1, dimerization protein | 10q25.2 | 4601 | NM_005962 | がん抑制遺伝子 | 腫瘍形成・増殖 | MYC |
MYB | MYB proto-oncogene, transcription factor | 6q23.3 | 4602 | NM_005375 | がん遺伝子 | 転写制御 | Transcriptional regulation |
MYC | MYC proto-oncogene, bHLH transcription factor | 8q24.21 | 4609 | NM_002467 | がん遺伝子 | 腫瘍形成・増殖 | MYC |
MYCL | MYCL proto-oncogene, bHLH transcription factor | 1p34.2 | 4610 | NM_001033081 | がん遺伝子 | 腫瘍形成・増殖 | MYC |
MYCN | MYCN proto-oncogene, bHLH transcription factor | 2p24.3 | 4613 | NM_001293228 | がん遺伝子 | 腫瘍形成・増殖 | MYC |
MYD88 | MYD88 innate immune signal transduction adaptor | 3p22.2 | 4615 | NM_002468 | がん遺伝子 | 腫瘍形成・増殖 | NFKB |
NAT2 | N-acetyltransferase 2 | 8p22 | 10 | NM_000015 | --- | 代謝 | Drug metabolism |
NBN | nibrin | 8q21.3 | 4683 | NM_002485 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
NCF2 | neutrophil cytosolic factor 2 | 1q25.3 | 4688 | NM_000433 | --- | --- | --- |
NCOA2 | nuclear receptor coactivator 2 | 8q13.3 | 10499 | NM_001321703 | がん遺伝子 | エピジェネティック制御 | Epigenetic modification |
NCOA3 | nuclear receptor coactivator 3 | 20q13.12 | 8202 | NM_181659 | がん遺伝子 | エピジェネティック制御 | Epigenetic modification |
NCOA4 | nuclear receptor coactivator 4 | 10q11.22 | 8031 | NM_001145262 | がん抑制遺伝子 | 転写制御 | Transcriptional regulation |
NCOR1 | nuclear receptor corepressor 1 | 17p12-p11.2 | 9611 | NM_006311 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
NF1 | neurofibromin 1 | 17q11.2 | 4763 | NM_001042492 | がん抑制遺伝子 | 腫瘍形成・増殖 | MAPK |
NF2 | neurofibromin 2 | 22q12.2 | 4771 | NM_000268 | がん抑制遺伝子 | 腫瘍形成・増殖 | Hippo |
NFE2L2 | nuclear factor, erythroid 2 like 2 | 2q31.2 | 4780 | NM_006164 | がん遺伝子 / がん抑制遺伝子 |
酸化ストレス応答 | KEAP1/NRF2 |
NFIB | nuclear factor I B | 9p23-p22.3 | 4781 | NM_005596 | --- | 転写制御 | Transcriptional regulation |
NFKBIA | NFKB inhibitor alpha | 14q13.2 | 4792 | NM_020529 | がん抑制遺伝子 | 腫瘍形成・増殖 | NFKB |
NKX2-1 | NK2 homeobox 1 | 14q13.3 | 7080 | NM_003317 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
NOTCH1 | notch receptor 1 | 9q34.3 | 4851 | NM_017617 | がん遺伝子 / がん抑制遺伝子 |
分化 | NOTCH |
NOTCH2 | notch receptor 2 | 1p12 | 4853 | NM_024408 | がん遺伝子 / がん抑制遺伝子 |
分化 | NOTCH |
NOTCH3 | notch receptor 3 | 19p13.12 | 4854 | NM_000435 | がん遺伝子 / がん抑制遺伝子 |
分化 | NOTCH |
NPM1 | nucleophosmin 1 | 5q35.1 | 4869 | NM_002520 | がん遺伝子 / がん抑制遺伝子 |
エピジェネティック制御 | Epigenetic modification |
NRAS | NRAS proto-oncogene, GTPase | 1p13.2 | 4893 | NM_002524 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
NRG1 | neuregulin 1 | 8p12 | 3084 | NM_013964 | がん抑制遺伝子 | 腫瘍形成・増殖 | RTK |
NT5C2 | 5'-nucleotidase, cytosolic II | 10q24.32-q24.33 | 22978 | NM_001134373 | がん遺伝子 | 代謝 | Metabolic pathway |
NTRK1 | neurotrophic receptor tyrosine kinase 1 | 1q23.1 | 4914 | NM_002529 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | RTK |
NTRK2 | neurotrophic receptor tyrosine kinase 2 | 9q21.33 | 4915 | NM_001018064 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
NTRK3 | neurotrophic receptor tyrosine kinase 3 | 15q25.3 | 4916 | NM_001012338 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
NUTM1 | NUT midline carcinoma family member 1 | 15q14 | 256646 | NM_001284292 | がん遺伝子 | --- | --- |
P2RY8 | P2Y receptor family member 8 | Xp22.33 / Yp11.2 | 286530 | NM_178129 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | GPCR |
PALB2 | partner and localizer of BRCA2 | 16p12.2 | 79728 | NM_024675 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
PRKN | parkin RBR E3 ubiquitin protein ligase | 6q26 | 5071 | NM_004562 | がん抑制遺伝子 | タンパク質の恒常性の維持 | Protein homeostasis |
PARP1 | poly(ADP-ribose) polymerase 1 | 1q42.12 | 142 | NM_001618 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
PARP2 | poly(ADP-ribose) polymerase 2 | 14q11.2 | 10038 | NM_005484 | --- | ゲノム安定性の維持 | DNA damage control |
PARP3 | poly(ADP-ribose) polymerase family member 3 | 3p21.2 | 10039 | NM_001003931 | --- | ゲノム安定性の維持 | DNA damage control |
PAX5 | paired box 5 | 9p13.2 | 5079 | NM_016734 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
PBRM1 | polybromo 1 | 3p21.1 | 55193 | NM_018313 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
PDCD1 | programmed cell death 1 | 2q37.3 | 5133 | NM_005018 | がん遺伝子 | 免疫 | Immune |
PDCD1LG2 | programmed cell death 1 ligand 2 | 9p24.1 | 80380 | NM_025239 | がん遺伝子 | 免疫 | Immune |
PDE11A | phosphodiesterase 11A | 2q31.2 | 50940 | NM_016953 | --- | 代謝 | Metabolic pathway |
PDGFB | platelet derived growth factor subunit B | 22q13.1 | 5155 | NM_002608 | がん遺伝子 | 代謝 | Metabolic pathway |
PDGFRA | platelet derived growth factor receptor alpha | 4q12 | 5156 | NM_006206 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
PDGFRB | platelet derived growth factor receptor beta | 5q32 | 5159 | NM_002609 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
PDK1 | pyruvate dehydrogenase kinase 1 | 2q31.1 | 5163 | NM_002610 | がん遺伝子 | 代謝 | Metabolic pathway |
PHOX2B | paired like homeobox 2B | 4p13 | 8929 | NM_003924 | がん抑制遺伝子 | 転写制御 | Transcriptional regulation |
PIK3C2B | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | 1q32.1 | 5287 | NM_002646 | --- | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
PIK3C2G | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma | 12p12.3 | 5288 | NM_004570 | --- | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 3q26.32 | 5290 | NM_006218 | がん遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
PIK3CB | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 3q22.3 | 5291 | NM_006219 | がん遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 7q22.3 | 5294 | NM_002649 | がん遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 | 5q13.1 | 5295 | NM_181523 | がん抑制遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
PIK3R2 | phosphoinositide-3-kinase regulatory subunit 2 | 19p13.11 | 5296 | NM_005027 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | PI3K/Akt/mTOR |
PIM1 | Pim-1 proto-oncogene, serine/threonine kinase | 6p21.2 | 5292 | NM_001243186 | がん遺伝子 | 腫瘍形成・増殖 | JAK/STAT |
PLAG1 | PLAG1 zinc finger | 8q12.1 | 5324 | NM_002655 | がん遺伝子 | 転写制御 | Transcriptional regulation |
PMS1 | PMS1 homolog 1, mismatch repair system component | 2q32.2 | 5378 | NM_001321047 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
PMS2 | PMS1 homolog 2, mismatch repair system component | 7p22.1 | 5395 | NM_000535 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
POLD1 | DNA polymerase delta 1, catalytic subunit | 19q13.33 | 5424 | NM_001256849 | がん抑制遺伝子 | ゲノム安定性の維持 | DNA damage control |
POLE | DNA polymerase epsilon, catalytic subunit | 12q24.33 | 5426 | NM_006231 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
POLH | DNA polymerase eta | 6p21.1 | 5429 | NM_006502 | --- | ゲノム安定性の維持 | DNA damage control |
PPARG | peroxisome proliferator activated receptor gamma | 3p25.2 | 5468 | NM_015869 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | Nuclear receptor |
PPP2R1A | protein phosphatase 2 scaffold subunit Aalpha | 19q13.41 | 5518 | NM_014225 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | PI3K/Akt/mTOR |
PPP2R2A | protein phosphatase 2 regulatory subunit Balpha | 8p21.2 | 5520 | NM_002717 | --- | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
PPP6C | protein phosphatase 6 catalytic subunit | 9q33.3 | 5537 | NM_002721 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
PRDM1 | PR/SET domain 1 | 6q21 | 639 | NM_001198 | がん抑制遺伝子 | 転写制御 | Transcriptional regulation |
PRKAR1A | protein kinase cAMP-dependent type I regulatory subunit alpha | 17q24.2 | 5573 | NM_212471 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | PI3K/Akt/mTOR |
PRKCI | protein kinase C iota | 3q26.2 | 5584 | NM_002740 | がん遺伝子 | 分化 | Hedgehog |
PTCH1 | patched 1 | 9q22.32 | 5727 | NM_000264 | がん抑制遺伝子 | 分化 | Hedgehog |
PTEN | phosphatase and tensin homolog | 10q23.31 | 5728 | NM_000314 | がん抑制遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
PTPN11 | protein tyrosine phosphatase non-receptor type 11 | 12q24.13 | 5781 | NM_002834 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
PTPRK | protein tyrosine phosphatase receptor type K | 6q22.33 | 5796 | NM_001291984 | がん抑制遺伝子 | 腫瘍形成・増殖 | RTK |
PTPRO | protein tyrosine phosphatase receptor type O | 12p12.3, 12p13-p12 | 5800 | NM_030667 | --- | 腫瘍形成・増殖 | RTK |
PTPRT | protein tyrosine phosphatase receptor type T | 20q12-q13.11 | 11122 | NM_007050 | がん抑制遺伝子 | 腫瘍形成・増殖 | RTK |
QKI | QKI, KH domain containing RNA binding | 6q26 | 9444 | NM_006775 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | RNA metabolism |
RAC1 | Rac family small GTPase 1 | 7p22.1 | 5879 | NM_006908 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
RAC2 | Rac family small GTPase 2 | 22q13.1 | 5880 | NM_002872 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
RAD21 | RAD21 cohesin complex component | 8q24.11 | 5885 | NM_006265 | がん遺伝子 / がん抑制遺伝子 |
細胞周期 | Cell division |
RAD50 | RAD50 double strand break repair protein | 5q31.1 | 10111 | NM_005732 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
RAD51 | RAD51 recombinase | 15q15.1 | 5888 | NM_002875 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
RAD51B | RAD51 paralog B | 14q24.1 | 5890 | NM_133509 | がん抑制遺伝子 | ゲノム安定性の維持 | DNA damage control |
RAD51C | RAD51 paralog C | 17q22 | 5889 | NM_058216 | がん抑制遺伝子 | ゲノム安定性の維持 | DNA damage control |
RAD51D | RAD51 paralog D | 17q12 | 5892 | NM_002878 | がん抑制遺伝子 | ゲノム安定性の維持 | DNA damage control |
RAD52 | RAD52 homolog, DNA repair protein | 12p13.33 | 5893 | NM_001297419 | --- | ゲノム安定性の維持 | Core DNA Damage Response |
RAD54L | RAD54 like | 1p34.1 | 8438 | NM_003579 | --- | ゲノム安定性の維持 | DNA damage control |
RAF1 | Raf-1 proto-oncogene, serine/threonine kinase | 3p25.2 | 5894 | NM_002880 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
RARA | retinoic acid receptor alpha | 17q21.2 | 5914 | NM_001145301 | がん遺伝子 | 腫瘍形成・増殖 | Nuclear receptor |
RB1 | RB transcriptional corepressor 1 | 13q14.2 | 5925 | NM_000321 | がん抑制遺伝子 | 細胞周期 | Cell cycle |
RBBP6 | RB binding protein 6, ubiquitin ligase | 16p12.1 | 5930 | NM_006910 | --- | タンパク質の恒常性の維持 | Protein homeostasis |
RBM10 | RNA binding motif protein 10 | Xp11.3 | 8241 | NM_005676 | がん抑制遺伝子 | 転写制御 | RNA metabolism |
RECQL4 | RecQ like helicase 4 | 8q24.3 | 9401 | NM_004260 | がん遺伝子 / がん抑制遺伝子 |
ゲノム安定性の維持 | DNA damage control |
REL | REL proto-oncogene, NF-kB subunit | 2p16.1 | 5966 | NM_002908 | がん遺伝子 | 腫瘍形成・増殖 | NFKB |
RET | ret proto-oncogene | 10q11.21 | 5979 | NM_020975 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
RHEB | Ras homolog, mTORC1 binding | 7q36.1 | 6009 | NM_005614 | がん遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
RHOA | ras homolog family member A | 3p21.31 | 387 | NM_001313941 | がん遺伝子 / がん抑制遺伝子 |
腫瘍形成・増殖 | MAPK |
RICTOR | RPTOR independent companion of MTOR complex 2 | 5p13.1 | 253260 | NM_152756 | がん遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
RIT1 | Ras like without CAAX 1 | 1q22 | 6016 | NM_006912 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
RNF43 | ring finger protein 43 | 17q22 | 54894 | NM_017763 | がん抑制遺伝子 | 分化 | WNT |
ROS1 | ROS proto-oncogene 1, receptor tyrosine kinase | 6q22.1 | 6098 | NM_002944 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
RPTOR | regulatory associated protein of MTOR complex 1 | 17q25.3 | 57521 | NM_020761 | がん遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
RRAS2 | RAS related 2 | 11p15.2 | 22800 | NM_012250 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
RSPO2 | R-spondin 2 | 8q23.1 | 340419 | NM_178565 | がん抑制遺伝子 | 分化 | WNT |
RSPO3 | R-spondin 3 | 6q22.33 | 84870 | NM_032784 | がん遺伝子 | 分化 | WNT |
RUNDC1 | RUN domain containing 1 | 17q21.31 | 146923 | NM_173079 | --- | --- | --- |
RUNX1 | RUNX family transcription factor 1 | 21q22.12 | 861 | NM_001001890 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
S1PR3 | sphingosine-1-phosphate receptor 3 | 9q22.1 | 1903 | NM_005226 | --- | 腫瘍形成・増殖 | GPCR |
SALL4 | spalt like transcription factor 4 | 20q13.2 | 57167 | NM_020436 | がん遺伝子 | 転写制御 | Transcriptional regulation |
SAMD9 | sterile alpha motif domain containing 9 | 7q21.2 | 54809 | NM_017654 | --- | --- | --- |
SDC4 | syndecan 4 | 20q13.12 | 6385 | NM_002999 | --- | --- | --- |
SDHA | succinate dehydrogenase complex flavoprotein subunit A | 5p15.33 | 6389 | NM_004168 | がん抑制遺伝子 | 代謝 | Metabolic pathway |
SDHAF2 | succinate dehydrogenase complex assembly factor 2 | 11q12.2 | 54949 | NM_017841 | がん抑制遺伝子 | 代謝 | Metabolic pathway |
SDHB | succinate dehydrogenase complex iron sulfur subunit B | 1p36.13 | 6390 | NM_003000 | がん抑制遺伝子 | 代謝 | Metabolic pathway |
SDHC | succinate dehydrogenase complex subunit C | 1q23.3 | 6391 | NM_003001 | がん抑制遺伝子 | 代謝 | Metabolic pathway |
SDHD | succinate dehydrogenase complex subunit D | 11q23.1 | 6392 | NM_003002 | がん抑制遺伝子 | 代謝 | Metabolic pathway |
SETBP1 | SET binding protein 1 | 18q12.3 | 26040 | NM_015559 | がん遺伝子 | エピジェネティック制御 | Epigenetic modification |
SETD2 | SET domain containing 2, histone lysine methyltransferase | 3p21.31 | 29072 | NM_014159 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
SF3B1 | splicing factor 3b subunit 1 | 2q33.1 | 23451 | NM_012433 | がん遺伝子 | 転写制御 | RNA metabolism |
SGK1 | serum/glucocorticoid regulated kinase 1 | 6q23.2 | 6446 | NM_005627 | がん遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
SH2D1A | SH2 domain containing 1A | Xq25 | 4068 | NM_002351 | がん抑制遺伝子 | 免疫 | Immune |
SHOC2 | SHOC2 leucine rich repeat scaffold protein | 10q25.2 | 8036 | NM_001324337 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
SKP2 | S-phase kinase associated protein 2 | 5p13.2 | 6502 | NM_005983 | がん遺伝子 | 細胞周期 | Cell cycle |
SLC22A18 | solute carrier family 22 member 18 | 11p15.4 | 5002 | NM_183233 | --- | 代謝 | Metabolic pathway |
SLC34A2 | solute carrier family 34 member 2 | 4p15.2 | 10568 | NM_006424 | がん抑制遺伝子 | --- | --- |
SLX4 | SLX4 structure-specific endonuclease subunit | 16p13.3 | 84464 | NM_032444 | がん抑制遺伝子 | ゲノム安定性の維持 | DNA damage control |
SMAD2 | SMAD family member 2 | 18q21.1 | 4087 | NM_001003652 | がん抑制遺伝子 | 腫瘍形成・増殖 | TGF-B |
SMAD4 | SMAD family member 4 | 18q21.2 | 4089 | NM_005359 | がん抑制遺伝子 | 腫瘍形成・増殖 | TGF-B |
SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 19p13.2 | 6597 | NM_001128844 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 22q11.23, 22q11 | 6598 | NM_003073 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
SMO | smoothened, frizzled class receptor | 7q32.1 | 6608 | NM_005631 | がん遺伝子 | 分化 | Hedgehog |
SNCAIP | synuclein alpha interacting protein | 5q23.2 | 9627 | NM_005460 | --- | --- | --- |
SOCS1 | suppressor of cytokine signaling 1 | 16p13.13 | 8651 | NM_003745 | がん抑制遺伝子 | 腫瘍形成・増殖 | JAK/STAT |
SOS1 | SOS Ras/Rac guanine nucleotide exchange factor 1 | 2p22.1 | 6654 | NM_005633 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
SOX2 | SRY-box transcription factor 2 | 3q26.33 | 6657 | NM_003106 | がん遺伝子 | 転写制御 | Transcriptional regulation |
SOX9 | SRY-box transcription factor 9 | 17q24.3 | 6662 | NM_000346 | がん遺伝子 / がん抑制遺伝子 |
分化 | WNT |
SPEN | spen family transcriptional repressor | 1p36.21-p36.13 | 23013 | NM_015001 | がん抑制遺伝子 | 転写制御 | Transcriptional regulation |
SPINK1 | serine peptidase inhibitor Kazal type 1 | 5q32 | 6690 | NM_003122 | --- | --- | --- |
SPOP | speckle type BTB/POZ protein | 17q21.33 | 8405 | NM_001007226 | がん遺伝子 / がん抑制遺伝子 |
タンパク質の恒常性の維持 | Protein homeostasis |
SRC | SRC proto-oncogene, non-receptor tyrosine kinase | 20q11.23 | 6714 | NM_005417 | がん遺伝子 | 腫瘍形成・増殖 | MAPK |
SS18 | SS18 subunit of BAF chromatin remodeling complex | 18q11.2 | 6760 | NM_001007559 | がん遺伝子 | 転写制御 | Transcriptional regulation |
SSX1 | SSX family member 1 | Xp11.23 | 6756 | NM_001278691 | がん遺伝子 | 転写制御 | Transcriptional regulation |
STAG2 | stromal antigen 2 | Xq25 | 10735 | NM_001042751 | がん抑制遺伝子 | 細胞周期 | Cell division |
STAT3 | signal transducer and activator of transcription 3 | 17q21.2 | 6774 | NM_139276 | がん遺伝子 | 腫瘍形成・増殖 | JAK/STAT |
STK11 | serine/threonine kinase 11 | 19p13.3 | 6794 | NM_000455 | がん抑制遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
STRN | striatin | 2p22.2 | 6801 | NM_003162 | --- | --- | --- |
SUFU | SUFU negative regulator of hedgehog signaling | 10q24.32 | 51684 | NM_016169 | がん抑制遺伝子 | 分化 | Hedgehog |
SYK | spleen associated tyrosine kinase | 9q22.2 | 6850 | NM_003177 | がん遺伝子 | 免疫 | Immune |
TACC3 | transforming acidic coiled-coil containing protein 3 | 4p16.3 | 10460 | NM_006342 | --- | 転写制御 | RNA metabolism |
TBX3 | T-box transcription factor 3 | 12q24.21 | 6926 | NM_016569 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
TCF7L2 | transcription factor 7 like 2 | 10q25.2-q25.3 | 6934 | NM_001146274 | がん遺伝子 / がん抑制遺伝子 |
分化 | WNT |
TEK | TEK receptor tyrosine kinase | 9p21.2 | 7010 | NM_000459 | --- | 腫瘍形成・増殖 | RTK |
TERC | telomerase RNA component | 3q26.2 | 7012 | NR_001566 | --- | ゲノム安定性の維持 | DNA damage control |
TERT | telomerase reverse transcriptase | 5p15.33 | 7015 | NM_198253 | がん遺伝子 / がん抑制遺伝子 |
ゲノム安定性の維持 | DNA damage control |
TET2 | tet methylcytosine dioxygenase 2 | 4q24 | 54790 | NM_001127208 | がん抑制遺伝子 | エピジェネティック制御 | Epigenetic modification |
TGFBR1 | transforming growth factor beta receptor 1 | 9q22.33 | 7046 | NM_004612 | がん抑制遺伝子 | 腫瘍形成・増殖 | TGF-B |
TGFBR2 | transforming growth factor beta receptor 2 | 3p24.1 | 7048 | NM_003242 | がん抑制遺伝子 | 腫瘍形成・増殖 | TGF-B |
TIPARP | TCDD inducible poly(ADP-ribose) polymerase | 3q25.31 | 25976 | NM_001184717 | --- | 代謝 | Metabolic pathway |
TMEM127 | transmembrane protein 127 | 2q11.2 | 55654 | NM_017849 | がん抑制遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
TMPRSS2 | transmembrane serine protease 2 | 21q22.3 | 7113 | NM_005656 | --- | 転写制御 | Transcriptional regulation |
TNFAIP3 | TNF alpha induced protein 3 | 6q23.3 | 7128 | NM_001270508 | がん抑制遺伝子 | 腫瘍形成・増殖 | NFKB |
TNFRSF14 | TNF receptor superfamily member 14 | 1p36.32 | 8764 | NM_003820 | がん抑制遺伝子 | 免疫 | Immune |
TNK2 | tyrosine kinase non receptor 2 | 3q29 | 10188 | NM_005781 | --- | 腫瘍形成・増殖 | RTK |
TP53 | tumor protein p53 | 17p13.1 | 7157 | NM_000546 | がん遺伝子 / がん抑制遺伝子 |
ゲノム安定性の維持 | TP53 |
TP63 | tumor protein p63 | 3q28 | 8626 | NM_003722 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
TPM3 | tropomyosin 3 | 1q21.3 | 7170 | NM_152263 | がん抑制遺伝子 | --- | --- |
TPMT | thiopurine S-methyltransferase | 6p22.3 | 7172 | NM_000367 | --- | 代謝 | Drug metabolism |
TRAF7 | TNF receptor associated factor 7 | 16p13.3 | 84231 | NM_032271 | がん抑制遺伝子 | タンパク質の恒常性の維持 | Protein homeostasis |
TSC1 | TSC complex subunit 1 | 9q34.13 | 7248 | NM_000368 | がん抑制遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
TSC2 | TSC complex subunit 2 | 16p13.3 | 7249 | NM_000548 | がん抑制遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
TSHR | thyroid stimulating hormone receptor | 14q31.1 | 7253 | NM_000369 | がん遺伝子 | 腫瘍形成・増殖 | GPCR |
TYRO3 | TYRO3 protein tyrosine kinase | 15q15.1 | 7301 | NM_006293 | --- | 腫瘍形成・増殖 | RTK |
U2AF1 | U2 small nuclear RNA auxiliary factor 1 | 21q22.3 | 7307 | NM_006758 | がん遺伝子 | 転写制御 | RNA metabolism |
UBE2T | ubiquitin conjugating enzyme E2 T | 1q32.1 | 29089 | NM_014176 | --- | ゲノム安定性の維持 | Core DNA Damage Response |
UGT1A1 | UDP glucuronosyltransferase family 1 member A1 | 2q37.1 | 54658 | NM_000463 | --- | 代謝 | Drug metabolism |
VEGFA | vascular endothelial growth factor A | 6p21.1 | 7422 | NM_001171623 | がん遺伝子 | 腫瘍形成・増殖 | RTK |
VHL | von Hippel-Lindau tumor suppressor | 3p25.3 | 7428 | NM_000551 | がん抑制遺伝子 | 腫瘍形成・増殖 | PI3K/Akt/mTOR |
VTI1A | vesicle transport through interaction with t-SNAREs 1A | 10q25.2 | 143187 | NM_145206 | --- | --- | --- |
NSD2 | nuclear receptor binding SET domain protein 2 | 4p16.3 | 7468 | NM_133330 | がん遺伝子 | エピジェネティック制御 | Epigenetic modification |
NSD3 | nuclear receptor binding SET domain protein 3 | 8p11.23 | 54904 | NM_023034 | がん遺伝子 | エピジェネティック制御 | Epigenetic modification |
WT1 | WT1 transcription factor | 11p13 | 7490 | NM_024426 | がん遺伝子 / がん抑制遺伝子 |
転写制御 | Transcriptional regulation |
XPA | XPA, DNA damage recognition and repair factor | 9q22.33 | 7507 | NM_000380 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
XPO1 | exportin 1 | 2p15 | 7514 | NM_003400 | がん遺伝子 | タンパク質の恒常性の維持 | Protein homeostasis |
XRCC2 | X-ray repair cross complementing 2 | 7q36.1 | 7516 | NM_005431 | がん抑制遺伝子 | ゲノム安定性の維持 | Core DNA Damage Response |
ZNF217 | zinc finger protein 217 | 20q13.2 | 7764 | NM_006526 | がん遺伝子 | 転写制御 | Transcriptional regulation |
ZNF703 | zinc finger protein 703 | 8p11.23 | 80139 | NM_025069 | --- | 転写制御 | Transcriptional regulation |